Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the ... [+] risk of heart attacks and strokes. The FDA said Ozempic can be used to reduce the risk of ...

Semaglutide, sold by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity, is part of a class of drugs known as GLP-1 receptor agonists, mimicking the hormone GLP-1 to reduce ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

DOCTOR, GOOD TO SEE YOU. YOU’VE LOOKED AT THIS NEW STUDY ABOUT OZEMPIC. AND FIRST OF ALL, IS IT OZEMPIC SPECIFICALLY? AND WHAT DOES IT SHOW? SO IT’S LOOKING SPECIFICALLY AT OZEMPIC ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug ... or liraglutide — are prescribed to treat type 2 diabetes and obesity, but previous studies have linked ...

Gradually increased to a maximum dose of 2.0 mg weekly. Common side effects include nausea, vomiting, diarrhea, and constipation. Consult your healthcare provider or the Ozempic medication guide ...